Neurones
NRO
ISIN FR0004050250 / Valor 837153
Neurones
UMushroom community rating:
About company
Neurones is a prominent entity in the field of consulting and IT services, leveraging the expertise of over 6,700 professionals. The company operates through a structured approach, dividing its operations into three main business segments to cater to the diverse needs of its clientele. These segments encompass a broad spectrum of services, including management consulting, organizational consulting, and digital transformation initiatives. Additionally, Neurones offers a comprehensive range of IT services, covering both infrastructure and application development. The firm is distinguished by its employment of consultants who bring a wealth of experience from their tenure at major international firms, ensuring a high level of expertise and service delivery. This strategic positioning allows Neurones to address the complex challenges of digital and organizational transformation faced by businesses today.
Summarized from source with an LLMView SourceSector: TechnologyLatest Results (07.03.2026):
NEURONES — 3rd quarter 2025: revenues for Q3 2025 amounted to €207.9m (vs €196.7m in Q3 2024), +5.7% reported and +5.1% organic; nine‑month revenues were €632.2m (+5.5% reported, +4.7% organic). The group reported a Q3 operating margin of 9.6% and a nine‑month operating margin of 8.4% (unaudited, after a 0.9% expense related to bonus shares). NEURONES says growth remained solid despite a declining French market and now targets full‑year revenues above €850m with operating profit of at least 8%.
Revenues (Q3 2025)
Q3 2025 revenues: €207.9m, up 5.7% year‑on‑year (organic growth +5.1%).
Year‑to‑date (end‑September 2025)
Nine‑month revenues: €632.2m, up 5.5% reported (+4.7% organic) versus the same period in 2024.
Profitability
Operating margin in Q3 2025 was 9.6%, improved versus the first half; nine‑month operating margin stood at 8.4% (unaudited and after including a 0.9% charge for bonus shares).
Business drivers
NEURONES reports particularly strong demand in Data & AI, digital projects, ITSM (ServiceNow) assignments and Business Process Management, which supported the quarter’s momentum.
Other operational note
The company statement notes that "turnover remained at a low level" (as reported by NEURONES), while overall activity and growth in the cited areas improved.
Outlook
Following Q3 improvement, NEURONES targets full‑year revenues above €850m and an operating profit margin of at least 8% for 2025.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
956 M
Market cap (USD)
24,032
Daily traded volume (Shares)
44.3 / 43.35
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
